Insider to sell 80,000 Confluent (NASDAQ: CFLT) shares under Rule 144
Rhea-AI Filing Summary
Confluent insider plans to sell common stock under Rule 144. A holder filed to sell 80,000 shares of Confluent common stock through Morgan Stanley Smith Barney, with an aggregate market value of
The shares to be sold were acquired by exercising stock options on
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for CFLT disclose about planned share sales?
The filing discloses an intention to sell 80,000 Confluent common shares under Rule 144. The planned sale, through Morgan Stanley Smith Barney, has an aggregate market value of
How were the 80,000 CFLT shares in the Form 144 acquired?
The 80,000 Confluent shares were acquired by exercising stock options on
How many Confluent (CFLT) shares are outstanding in this Form 144?
The notice states that 308,661,566 Confluent common shares were outstanding. This figure provides context for the planned 80,000-share sale, helping investors gauge the relative size of the transaction compared with the company’s total share count.
Which broker is handling the planned CFLT Rule 144 share sale?
The planned sale of 80,000 Confluent common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. Their listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are listed on NASDAQ.
What recent 10b5-1 plan sales related to CFLT are listed in the Form 144?
The notice lists several recent 10b5-1 sales of Confluent common stock in December 2025. Sellers include entities associated with David Stein, Trouvaille Investments Holdings Ltd, and Neha Narkhede, with individual sale amounts ranging from 23,100 to 333,333 shares.
On what date is the CFLT Rule 144 sale expected to occur?
The approximate date of sale for the 80,000 Confluent common shares is listed as